Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Background Although recent epidemiological data suggest that pneumococci may contribute to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in patients with coronavirus disease 2019 (COVID-19) during hospitalization have been reported infrequently. This apparent con...
Main Authors: | Elena Mitsi, Jesús Reiné, Britta C. Urban, Carla Solórzano, Elissavet Nikolaou, Angela D. Hyder-Wright, Sherin Pojar, Ashleigh Howard, Lisa Hitchins, Sharon Glynn, Madlen C. Farrar, Konstantinos Liatsikos, Andrea M. Collins, Naomi F. Walker, Helen C. Hill, Esther L. German, Katerina S. Cheliotis, Rachel L. Byrne, Christopher T. Williams, Ana I. Cubas-Atienzar, Tom E. Fletcher, Emily R. Adams, Simon J. Draper, David Pulido, Rohini Beavon, Christian Theilacker, Elizabeth Begier, Luis Jodar, Bradford D. Gessner, Daniela M. Ferreira |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-04-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI157124 |
Similar Items
-
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
by: Mitsi, E, et al.
Published: (2022) -
Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis
by: Katerina S. Cheliotis, et al.
Published: (2022-04-01) -
Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort study.
by: Naomi F Walker, et al.
Published: (2023-01-01) -
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127
by: Christian Theilacker, et al.
Published: (2022-05-01) -
PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
by: Christian Theilacker, et al.
Published: (2022-01-01)